News

2024-08-30 | Company

New Global Director of Human Resources

We are happy to announce that Stefan Petersson has been appointed as Global HR Director.

Read more

2024-08-01 | Company

CIFF To Propel PrEP Revolution with up to US$2 Million for Immediate Access to PrEP Rings

Here you can read the latest press release from The Global Fund and The Children’s Investment Fund Foundation, explaining how PrEP rings, manufactured in Sweden by Sever Pharma Solutions, make a difference for women in Africa.

Read more

2024-07-05 | Company

Sustainability report 2023

Our ability to achieve business success and deliver long-term customer value depends on our systematic and strategic efforts to monitor and enhance our global sustainability impact.

Read more

2023-12-21 | Company

Sever Pharma Solutions Secures DEA License for Controlled Substances Handling in Putnam, CT

Sever Pharma Solutions, a leading Contract Development and Manufacturing Organization (CDMO) specializing in controlled release systems for highly potent drugs is pleased to announce the successful attainment of the Drug Enforcement Administration (DEA) license for its site in Putnam, CT.

Read more

2023-12-19 | Company

Company report 2022

During 2022, we initiated the expansion of the R&D capacity at our US site in Putnam and increased our capabilities with a new line for aseptic fill and finish. Read the full company report.

Read more

2023-10-18 | Company

Sever Pharma Solutions Expands Capabilities with Approval of New Aseptic Filling Line for High Potent Injectable Drugs in Malmo Site

We pleased to announce the approval by the Swedish Health authorities of its state-of-the-art aseptic filling line for syringes, specifically designed for high potent injectable drugs, at its Malmo site.

Read more

2023-10-11 | Company

New Director of Supply Chain Management

We are happy to announce that Kristian Ahlgren has been appointed as Director of Supply Chain Management.

Read more

2023-09-21 | Company

Sever Pharma Solutions breaks ground with new high potency drug manufacturing suites

[Putnam, CT, USA - Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI) manufacturing suites.

Read more